View allAll Photos Tagged Biohacks
Southern California twilight. The last quarter moon. .77mL drawn from an American Regent vial, glass catching purple. A BD syringe glimmers. Skin kissed clean with a Rugby alcohol wipe. This isn’t medicine it’s magic. The high where your soul turns Technicolor. The crayons sharpen themselves. You pine instead of lust. You love without claws. Creativity drips out like honey. eGirl alchemy, biohacked in muscle.
#USA #Biohack #EstradiolMagic #BDsyringes #RugbyClean #AmericanRegent
A container of DotNotAge Pure Quercetin, a longevity supplement by longevity expert Ben Hoffman
If you wish to use this image, please attribute as follows "by Ben Hoffman at longevityfaq.com;"
Resumen Orbes: Salud, Biohacking y Longevidad es una brújula práctica para navegar un tema que mezcla ciencia, hábitos y tendencias. Hoy convivimos con dos fuerzas: por un lado, evidencia sólida sobre lo que realmente mejora la salud; por otro, una avalancha de “hacks” prometiendo resultados rápidos. En Orbes, la idea no es perseguir lo raro, sino construir longevidad funcional: vivir más años con energía, movilidad, claridad mental y bajo riesgo cardiometabólico.
#Salud #Biohacking #Longevidad #Bienestar #vidasana
Más información: orbesargentina.com/resumen-orbes-salud-biohacking-longevi...
These types of biohacking might have answered the question “what is Biohacking” yet the variety of biohacking practices is wide. We picked five biohacking examples that you can try right away and start experiencing their health benefits.
Full article: www.antiagingninjas.com/what-is-biohacking/
When I met Eric Topol at Scripps Research, he greeted me with an easy calm, the sort of quiet steadiness that settles a room without ever trying to command it. There is no theatricality about him. No hint of the celebrity doctor, even though he easily could play that role. His curiosity comes first. You feel it immediately. He listens closely, as if the next idea might arrive from anywhere.
Topol has spent decades at the frontier of cardiovascular medicine, genomics, and digital health. He trained as a cardiologist at a time when heart attacks were often a sudden, devastating surprise. Much of his early work focused on clot-busting therapies and transforming acute cardiac care. That alone would have secured a distinguished career. But he did not stop there. He moved into genetics and then into the rapidly evolving intersection of medicine and data, asking how sequencing, wearable sensors, and artificial intelligence might change how we prevent disease rather than simply react to it.
He founded and directs the Scripps Research Translational Institute, where the emphasis is clear: translate discovery into real human benefit. Not hype. Not products. Not a quick fix. In a landscape crowded with longevity influencers and supplement stacks, Topol stands apart. He does not take sponsorships to push powders or pills. He is not interested in monetizing fear. If anything, he seems slightly allergic to the noise.
His focus is more austere and, in many ways, more radical. Diet. Sleep. Exercise. Social connection. The fundamentals. He talks about “super agers,” people who reach their eighties with the physiology of someone decades younger, and he does so with data in hand. What patterns do they share? What biomarkers remain resilient? How does inflammation behave across time? For Topol, longevity is not about chasing immortality. It is about compressing morbidity, extending healthspan, and preserving function.
In his recent writing, particularly in his book Super Agers, he leans into the evidence that aging is not a single uniform decline but a mosaic. Some systems falter early. Others remain robust. With genomic insight and longitudinal data, medicine can begin to map this mosaic and intervene earlier. But he is careful. He does not promise magic. He points instead to measurable behaviors: regular aerobic activity, resistance training, high-quality sleep, nutrient-dense food, minimizing ultra-processed diets. He is skeptical of supplement culture because most of it runs ahead of the evidence. If a molecule works, he believes, it should prove itself in rigorous trials.
There is also a democratizing instinct in his work. He has been outspoken about the need to make genomic testing and advanced diagnostics more accessible. He sees a future where medicine is individualized, where a person’s risk for atrial fibrillation or Alzheimer’s disease can be flagged early, and where prevention is not reserved for the affluent. He is equally vocal about the ethical tensions of AI in healthcare. Algorithms must augment clinicians, not replace empathy. Data must serve patients, not corporations.
When I photographed him, I was struck by the absence of cynicism. He has seen enough of the system to justify it. Yet he still believes that medicine can be reoriented toward prevention and personalization without losing its human core. There is a steadiness in him that mirrors his message. No flashy claims. No performative biohacking. Just the disciplined accumulation of evidence and a commitment to follow it wherever it leads.
In the end, Eric Topol represents a particular kind of authority that feels increasingly rare. Not the authority of charisma, but of rigor. Not the seduction of miracle cures, but the persistence of science. In a culture that wants shortcuts, he keeps returning to first principles. Move your body. Sleep deeply. Eat real food. Stay connected. Let the data guide you. And above all, protect the integrity of medicine from the distortions of commerce.
Standing in that quiet room at Scripps, you sense that his project is larger than longevity. It is about restoring trust in the idea that health is built, patiently and measurably, over time.
When I met Eric Topol at Scripps Research, he greeted me with an easy calm, the sort of quiet steadiness that settles a room without ever trying to command it. There is no theatricality about him. No hint of the celebrity doctor, even though he easily could play that role. His curiosity comes first. You feel it immediately. He listens closely, as if the next idea might arrive from anywhere.
Topol has spent decades at the frontier of cardiovascular medicine, genomics, and digital health. He trained as a cardiologist at a time when heart attacks were often a sudden, devastating surprise. Much of his early work focused on clot-busting therapies and transforming acute cardiac care. That alone would have secured a distinguished career. But he did not stop there. He moved into genetics and then into the rapidly evolving intersection of medicine and data, asking how sequencing, wearable sensors, and artificial intelligence might change how we prevent disease rather than simply react to it.
He founded and directs the Scripps Research Translational Institute, where the emphasis is clear: translate discovery into real human benefit. Not hype. Not products. Not a quick fix. In a landscape crowded with longevity influencers and supplement stacks, Topol stands apart. He does not take sponsorships to push powders or pills. He is not interested in monetizing fear. If anything, he seems slightly allergic to the noise.
His focus is more austere and, in many ways, more radical. Diet. Sleep. Exercise. Social connection. The fundamentals. He talks about “super agers,” people who reach their eighties with the physiology of someone decades younger, and he does so with data in hand. What patterns do they share? What biomarkers remain resilient? How does inflammation behave across time? For Topol, longevity is not about chasing immortality. It is about compressing morbidity, extending healthspan, and preserving function.
In his recent writing, particularly in his book Super Agers, he leans into the evidence that aging is not a single uniform decline but a mosaic. Some systems falter early. Others remain robust. With genomic insight and longitudinal data, medicine can begin to map this mosaic and intervene earlier. But he is careful. He does not promise magic. He points instead to measurable behaviors: regular aerobic activity, resistance training, high-quality sleep, nutrient-dense food, minimizing ultra-processed diets. He is skeptical of supplement culture because most of it runs ahead of the evidence. If a molecule works, he believes, it should prove itself in rigorous trials.
There is also a democratizing instinct in his work. He has been outspoken about the need to make genomic testing and advanced diagnostics more accessible. He sees a future where medicine is individualized, where a person’s risk for atrial fibrillation or Alzheimer’s disease can be flagged early, and where prevention is not reserved for the affluent. He is equally vocal about the ethical tensions of AI in healthcare. Algorithms must augment clinicians, not replace empathy. Data must serve patients, not corporations.
When I photographed him, I was struck by the absence of cynicism. He has seen enough of the system to justify it. Yet he still believes that medicine can be reoriented toward prevention and personalization without losing its human core. There is a steadiness in him that mirrors his message. No flashy claims. No performative biohacking. Just the disciplined accumulation of evidence and a commitment to follow it wherever it leads.
In the end, Eric Topol represents a particular kind of authority that feels increasingly rare. Not the authority of charisma, but of rigor. Not the seduction of miracle cures, but the persistence of science. In a culture that wants shortcuts, he keeps returning to first principles. Move your body. Sleep deeply. Eat real food. Stay connected. Let the data guide you. And above all, protect the integrity of medicine from the distortions of commerce.
Standing in that quiet room at Scripps, you sense that his project is larger than longevity. It is about restoring trust in the idea that health is built, patiently and measurably, over time.
Pure Phoenix
Pure Phoenix in Scottsdale specializes in Lymphatic Enhancement Therapy using the LymphStar Pro Fusion device. We blend biohacking and holistic care to reduce inflammation, detoxify, and restore vitality for post-surgery recovery, chronic illness, and overall wellness.
Address: 7950 E Redfield Rd, Ste 250, Scottsdale, AZ 85260, USA
Phone: 480-494-5211
Website: purephoenix.com
When I met Eric Topol at Scripps Research, he greeted me with an easy calm, the sort of quiet steadiness that settles a room without ever trying to command it. There is no theatricality about him. No hint of the celebrity doctor, even though he easily could play that role. His curiosity comes first. You feel it immediately. He listens closely, as if the next idea might arrive from anywhere.
Topol has spent decades at the frontier of cardiovascular medicine, genomics, and digital health. He trained as a cardiologist at a time when heart attacks were often a sudden, devastating surprise. Much of his early work focused on clot-busting therapies and transforming acute cardiac care. That alone would have secured a distinguished career. But he did not stop there. He moved into genetics and then into the rapidly evolving intersection of medicine and data, asking how sequencing, wearable sensors, and artificial intelligence might change how we prevent disease rather than simply react to it.
He founded and directs the Scripps Research Translational Institute, where the emphasis is clear: translate discovery into real human benefit. Not hype. Not products. Not a quick fix. In a landscape crowded with longevity influencers and supplement stacks, Topol stands apart. He does not take sponsorships to push powders or pills. He is not interested in monetizing fear. If anything, he seems slightly allergic to the noise.
His focus is more austere and, in many ways, more radical. Diet. Sleep. Exercise. Social connection. The fundamentals. He talks about “super agers,” people who reach their eighties with the physiology of someone decades younger, and he does so with data in hand. What patterns do they share? What biomarkers remain resilient? How does inflammation behave across time? For Topol, longevity is not about chasing immortality. It is about compressing morbidity, extending healthspan, and preserving function.
In his recent writing, particularly in his book Super Agers, he leans into the evidence that aging is not a single uniform decline but a mosaic. Some systems falter early. Others remain robust. With genomic insight and longitudinal data, medicine can begin to map this mosaic and intervene earlier. But he is careful. He does not promise magic. He points instead to measurable behaviors: regular aerobic activity, resistance training, high-quality sleep, nutrient-dense food, minimizing ultra-processed diets. He is skeptical of supplement culture because most of it runs ahead of the evidence. If a molecule works, he believes, it should prove itself in rigorous trials.
There is also a democratizing instinct in his work. He has been outspoken about the need to make genomic testing and advanced diagnostics more accessible. He sees a future where medicine is individualized, where a person’s risk for atrial fibrillation or Alzheimer’s disease can be flagged early, and where prevention is not reserved for the affluent. He is equally vocal about the ethical tensions of AI in healthcare. Algorithms must augment clinicians, not replace empathy. Data must serve patients, not corporations.
When I photographed him, I was struck by the absence of cynicism. He has seen enough of the system to justify it. Yet he still believes that medicine can be reoriented toward prevention and personalization without losing its human core. There is a steadiness in him that mirrors his message. No flashy claims. No performative biohacking. Just the disciplined accumulation of evidence and a commitment to follow it wherever it leads.
In the end, Eric Topol represents a particular kind of authority that feels increasingly rare. Not the authority of charisma, but of rigor. Not the seduction of miracle cures, but the persistence of science. In a culture that wants shortcuts, he keeps returning to first principles. Move your body. Sleep deeply. Eat real food. Stay connected. Let the data guide you. And above all, protect the integrity of medicine from the distortions of commerce.
Standing in that quiet room at Scripps, you sense that his project is larger than longevity. It is about restoring trust in the idea that health is built, patiently and measurably, over time.
When I met Eric Topol at Scripps Research, he greeted me with an easy calm, the sort of quiet steadiness that settles a room without ever trying to command it. There is no theatricality about him. No hint of the celebrity doctor, even though he easily could play that role. His curiosity comes first. You feel it immediately. He listens closely, as if the next idea might arrive from anywhere.
Topol has spent decades at the frontier of cardiovascular medicine, genomics, and digital health. He trained as a cardiologist at a time when heart attacks were often a sudden, devastating surprise. Much of his early work focused on clot-busting therapies and transforming acute cardiac care. That alone would have secured a distinguished career. But he did not stop there. He moved into genetics and then into the rapidly evolving intersection of medicine and data, asking how sequencing, wearable sensors, and artificial intelligence might change how we prevent disease rather than simply react to it.
He founded and directs the Scripps Research Translational Institute, where the emphasis is clear: translate discovery into real human benefit. Not hype. Not products. Not a quick fix. In a landscape crowded with longevity influencers and supplement stacks, Topol stands apart. He does not take sponsorships to push powders or pills. He is not interested in monetizing fear. If anything, he seems slightly allergic to the noise.
His focus is more austere and, in many ways, more radical. Diet. Sleep. Exercise. Social connection. The fundamentals. He talks about “super agers,” people who reach their eighties with the physiology of someone decades younger, and he does so with data in hand. What patterns do they share? What biomarkers remain resilient? How does inflammation behave across time? For Topol, longevity is not about chasing immortality. It is about compressing morbidity, extending healthspan, and preserving function.
In his recent writing, particularly in his book Super Agers, he leans into the evidence that aging is not a single uniform decline but a mosaic. Some systems falter early. Others remain robust. With genomic insight and longitudinal data, medicine can begin to map this mosaic and intervene earlier. But he is careful. He does not promise magic. He points instead to measurable behaviors: regular aerobic activity, resistance training, high-quality sleep, nutrient-dense food, minimizing ultra-processed diets. He is skeptical of supplement culture because most of it runs ahead of the evidence. If a molecule works, he believes, it should prove itself in rigorous trials.
There is also a democratizing instinct in his work. He has been outspoken about the need to make genomic testing and advanced diagnostics more accessible. He sees a future where medicine is individualized, where a person’s risk for atrial fibrillation or Alzheimer’s disease can be flagged early, and where prevention is not reserved for the affluent. He is equally vocal about the ethical tensions of AI in healthcare. Algorithms must augment clinicians, not replace empathy. Data must serve patients, not corporations.
When I photographed him, I was struck by the absence of cynicism. He has seen enough of the system to justify it. Yet he still believes that medicine can be reoriented toward prevention and personalization without losing its human core. There is a steadiness in him that mirrors his message. No flashy claims. No performative biohacking. Just the disciplined accumulation of evidence and a commitment to follow it wherever it leads.
In the end, Eric Topol represents a particular kind of authority that feels increasingly rare. Not the authority of charisma, but of rigor. Not the seduction of miracle cures, but the persistence of science. In a culture that wants shortcuts, he keeps returning to first principles. Move your body. Sleep deeply. Eat real food. Stay connected. Let the data guide you. And above all, protect the integrity of medicine from the distortions of commerce.
Standing in that quiet room at Scripps, you sense that his project is larger than longevity. It is about restoring trust in the idea that health is built, patiently and measurably, over time.
International collaborative applied ecological research, development and dissemination www.hackteria.org/hackterialab/hlab14/
International collaborative applied ecological research, development and dissemination www.hackteria.org/hackterialab/hlab14/
International collaborative applied ecological research, development and dissemination www.hackteria.org/hackterialab/hlab14/
Southern California twilight. The last quarter moon. .77mL drawn from an American Regent vial, glass catching purple. A BD syringe glimmers. Skin kissed clean with a Rugby alcohol wipe. This isn’t medicine it’s magic. The high where your soul turns Technicolor. The crayons sharpen themselves. You pine instead of lust. You love without claws. Creativity drips out like honey. eGirl alchemy, biohacked in muscle.
#USA #Biohack #EstradiolMagic #BDsyringes #RugbyClean #AmericanRegent
Southern California twilight. The last quarter moon. .77mL drawn from an American Regent vial, glass catching purple. A BD syringe glimmers. Skin kissed clean with a Rugby alcohol wipe. This isn’t medicine it’s magic. The high where your soul turns Technicolor. The crayons sharpen themselves. You pine instead of lust. You love without claws. Creativity drips out like honey. eGirl alchemy, biohacked in muscle.
#USA #Biohack #EstradiolMagic #BDsyringes #RugbyClean #AmericanRegent